| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3302331 | Gastrointestinal Endoscopy | 2015 | 13 Pages |
Abstract
Endoluminal therapy can successfully achieve eradication of IM and dysplasia or neoplasia in BE patients with HGD and IMC at comparable rates. There were no differences in the rates of recurrent HGD/IMC in the 2 groups.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Aaron J. MD, MSCE, Scott E. MD, Jessica S. BA, Carlos MD, PhD, Emma E. MD, Michael L. MD, Kimberly A. MD, MHS, Meenakshi MD, MPH, PhD, Gary W. MD, MS, Gregory G. MD,